Drawing for BRILL PHARMA

USPTO serial 79296244

BRILL PHARMA

Reviewed by CopyMark Law Group

Reg. 6488638Status 700Renewal
Filing date
Status date
Registration date
Sep 21, 2021
Examiner
BLANDU, FLORENTINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BRILL PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Sanitary preparations and products thereof, namely, sanitary sterilizing preparations; dental preparations and articles, namely, dental adhesives as well as medicinal dentifrices; products for air deodorizing and purification, namely, air deodorizing and air purification preparations; products and preparations for pest control, namely, granular repellant for burrowing pests; dietetic preparations and supplements, namely, dietary and nutritional supplements; sanitary articles and preparations, namely, feminine hygiene pads; disinfectants and antiseptics; disinfecting and medicinal detergents and soaps; absorbent products for personal hygiene, namely, antibacterial skin soaps; collyrium; ophthalmological preparations; chemical preparations for sanitary use; hygienic and sanitary products for medical use, namely, cleaning solutions for medical use; therapeutic drugs; agents for administering medicines namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; medicines, namely, pharmaceutical preparations for ophthalmological useACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 6, 2026ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Feb 5, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED
Nov 13, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Apr 23, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 23, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 23, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 26, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Mar 9, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Mar 9, 2022FIMPFINAL DISPOSITION PROCESSED
Dec 21, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 21, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 19, 2021GPNXNOTIFICATION PROCESSED BY IB
Jul 6, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 6, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 30, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 30, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 16, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 1, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jun 1, 2021XAECEXAMINER'S AMENDMENT ENTERED
Jun 1, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 1, 2021GNEAEXAMINERS AMENDMENT E-MAILED
Jun 1, 2021CNEAEXAMINERS AMENDMENT -WRITTEN
May 7, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 6, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 6, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 7, 2021RFNTREFUSAL PROCESSED BY IB
Feb 18, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 18, 2021RFRRREFUSAL PROCESSED BY MPU
Feb 5, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 4, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 28, 2021DOCKASSIGNED TO EXAMINER
Oct 27, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Oct 23, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 22, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance